Skip to content

A prospective randomized controlled trial of FGG combined with periodontal tissue regeneration two-stage method for the treatment of intrabony defects with insufficient keratinized gingival width

A prospective randomized controlled trial of FGG combined with periodontal tissue regeneration two-stage method for the treatment of intrabony defects with insufficient keratinized gingival width

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063180
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

Experimental group:FGG combined with periodontal tissue regeneration two-stage method
Control group:periodontal tissue regeneration

Sponsors

Shanghai Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Diagnosed with stage III or IV Grade C periodontitis according to the 2017 consensus classification of periodontal disease and peri-implant diseases and conditions; 3. According to imaging examination, there was at least one subosseous defect with depth >=3mm on both sides; 4. The keratinized gingival width of the defect site is less than 2mm; 5. Probing depth (PD) in subbone defect sites was >=5mm and Bleeding Index (BI) was >=2. 6. Live pulp or complete root canal treatment; 7. Good compliance, good oral hygiene habits; 8. Access to informed consent.

Exclusion criteria

Exclusion criteria: 1. Smoking; 2. Pregnant or lactating patients; 3. Patients suffering from tumor, diabetes, cardiovascular disease and other systemic diseases; 4. Any situation that is not suitable for periodontal surgery; 5. The affected tooth has III degrees root bifurcation lesion or III degrees loosening; 6. Periodontal operation was performed on the affected tooth; 7. The investigator considered that other reasons were not suitable for this clinical trial.

Design outcomes

Primary

MeasureTime frame
change of clinical attachment loss;

Secondary

MeasureTime frame
change of clinical attachment loss;change of probing depth;changes in intrabony defect depth and vertical bone loss;change of keratinized tissue width;

Countries

China

Contacts

Public ContactChen Meihua

Shanghai Stomatological Hospital

cathychendt@163.com+86 21 63601025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026